About B. Braun
B. Braun is a German medical and pharmaceutical device company with more than 63,000 employees globally, and offices and production facilities in more than 60 countries. Its headquarters are located in Melsungen, in central Germany. The company was founded in 1839 and is still owned by the Braun family.
B. Braun has more than 5,000 different healthcare products, of which 95% are manufactured by the company. In 2018, the company had a revenue of 6.908 Billion Euros.
From Wikipedia: read the full article · text available under CC BY-SA 4.0
B. Braun timeline
- 1839
- 🏁· approximateFounded
Events of B. Braun from Wikidata. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.
Market cap history
Not enough history yet.
FDA drug approvals: B. Braun#
123 approved applications held, 1 of them new molecular entities; 4 approvals and 0 new uses in 2025.
| Approved | Drug | Kind |
|---|---|---|
| 2025-10-24 | Rocuronium BromideRocuronium Bromide · NDA219108 | New drug (NDA) |
| 2025-08-05 | Sugammadex SodiumSugammadex Sodium · ANDA214279 | Generic drug (ANDA) |
| 2025-05-01 | Midazolam In 0.8% Sodium ChlorideMidazolam · ANDA218454 | Generic drug (ANDA) |
| 2025-04-03 | Piperacillin And Tazobactam And Sodium Chloride In Duplex ContainerPiperacillin Sodium, Tazobactam Sodium · NDA206056 | New drug (NDA) |
| 2024-12-09 | TromethamineTromethamine · ANDA211558 | Generic drug (ANDA) |
| 2024-08-26 | Cefazolin And Dextrosenew useCefazolin Sodium · NDA050779 (SUPPL-34) | New drug (NDA) |
| 2024-02-27 | Levetiracetam In Sodium ChlorideLevetiracetam · ANDA209705 | Generic drug (ANDA) |
| 2023-08-21 | Calcium GluconateCalcium Gluconate · ANDA216541 | Generic drug (ANDA) |
| 2021-09-08 | Lidocaine Hydrochloride And EpinephrineEpinephrine, Lidocaine Hydrochloride · ANDA208475 | Generic drug (ANDA) |
| 2021-04-26 | Magnesium SulfateMagnesium Sulfate · ANDA207967 | Generic drug (ANDA) |
| 2021-02-18 | AcetaminophenAcetaminophen · NDA204957 | New drug (NDA) |
| 2020-11-23 | Cefazolin And Dextrosenew useCefazolin Sodium · NDA050779 (SUPPL-27) | New drug (NDA) |
| 2020-10-27 | Magnesium Sulfate In Dextrose 5% In Plastic ContainerMagnesium Sulfate · ANDA207966 | Generic drug (ANDA) |
| 2019-09-24 | Mannitol 20% In Plastic Container, Mannitol 10% In Plastic Container, Mannitol 15% In Plastic Container, Mannitol 5% In Plastic Containernew useMannitol · NDA020006 (SUPPL-28) | New drug (NDA) |
| 2019-04-02 | Bupivacaine HydrochlorideBupivacaine Hydrochloride · ANDA209087 | Generic drug (ANDA) |
| 2018-11-19 | Heparin SodiumHeparin Sodium · ANDA208827 | Generic drug (ANDA) |
| 2018-08-03 | Lidocaine HydrochlorideLidocaine Hydrochloride · ANDA208474 | Generic drug (ANDA) |
| 2017-09-26 | ClorotekalChloroprocaine Hydrochloride · NDA208791 | New drug (NDA) |
| 2015-04-30 | Meropenem And Sodium Chloride In Duplex ContainerMeropenem · NDA202106 | New drug (NDA) |
| 2014-09-18 | Cefazolin And Dextrosenew useCefazolin Sodium · NDA050779 (SUPPL-23) | New drug (NDA) |
| 2012-04-13 | Amino AcidsAmino Acids · ANDA091112 | Generic drug (ANDA) |
| 2012-01-13 | Cefazolin And Dextrosenew useCefazolin Sodium · NDA050779 (SUPPL-18) | New drug (NDA) |
| 2011-06-13 | Ceftazidime In Dextrose ContainerCeftazidime · NDA050823 | New drug (NDA) |
| 2010-05-06 | Cefepime And Dextrose In Duplex ContainerCefepime Hydrochloride · NDA050821 | New drug (NDA) |
| 2010-02-03 | Balanced SaltCalcium Chloride, Magnesium Chloride, Potassium Chloride, Sodium Acetate, Sodium Chloride, Sodium Citrate · ANDA091387 | Generic drug (ANDA) |
Source: Drugs@FDA (openFDA). Approvals are listed under the application's current holder (B BRAUN and B BRAUN MEDICAL), so they follow acquisitions
Peer comparison · Healthcare
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| B. Braun🇩🇪 | — | — | — | — |
| Eli Lilly and Company🇺🇸 | $1.20 T | 43.4× | 31.9% | +44.7% |
| Johnson & Johnson🇺🇸 | $652.5 B | 40.5× | 16.2% | +6.0% |
| AbbVie Inc.🇺🇸 | $514.0 B | 49.7× | 15.7% | +8.6% |
| Roche Holding AG🇨🇭 | $370.3 B | 29.1× | 19.0% | — |
| UnitedHealth Group Incorporated🇺🇸 | $367.7 B | 23.1× | 3.5% | +11.8% |
| Merck & Co., Inc.🇺🇸 | $359.8 B | 146.7× | 3.6% | +1.3% |
| Novartis AG🇨🇭 | $286.8 B | 20.5× | 24.7% | — |
| Thermo Fisher Scientific Inc.🇺🇸 | $253.8 B | 35.9× | 14.9% | +3.9% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Compare head to head
Similar companies by size and industry
- Eli Lilly and Company$1.20 T
- Johnson & Johnson$652.5 B
- AbbVie Inc.$514.0 B
- Roche Holding AG$370.3 B
- UnitedHealth Group Incorporated$367.7 B
- Merck & Co., Inc.$359.8 B
Sources and freshness
- Profile updated:
- Nov 5, 2026
Figures from Wikidata, Wikipedia, Wikimedia Commons, value.today research.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at B. Braun? Verify and update this profile — free
Show B. Braun's ranking on your website Get the badge
The badge updates itself as the ranking changes.